Efficacy of Interferon Gamma in the Prevention of SARS-CoV-2 Infection (COVID-19): Results of a Prospective Controlled Trial
Background: To date, there is no evidence supporting the effectiveness of the use of any drugs for the prevention of COVID-19. However, we have a number of promising drugs at our disposal, which may be potential candidates in COVID-19 prevention. The main aim of this study was to assess the prevalen...
Main Authors: | Alexander L. Myasnikov, Svetlana A. Berns, Konstantin V. Zverev, Olga A. Lartseva, Pavel A. Talyzin |
---|---|
Format: | Article |
Language: | English |
Published: |
International Medical Research and Development Corporation
2020-09-01
|
Series: | International Journal of Biomedicine |
Subjects: | |
Online Access: | http://ijbm.org/articles/i39/ijbm_10(3)_oa1.pdf |
Similar Items
-
Broad T Cell Targeting of Structural Proteins After SARS-CoV-2 Infection: High Throughput Assessment of T Cell Reactivity Using an Automated Interferon Gamma Release Assay
by: Isabel Brand, et al.
Published: (2021-05-01) -
Pre-existing T-cell immunity to SARS-CoV-2 in unexposed healthy controls in Ecuador, as detected with a COVID-19 Interferon-Gamma Release Assay
by: Gustavo Echeverría, et al.
Published: (2021-04-01) -
Immune evasion of SARS-CoV-2 from interferon antiviral system
by: Yuan-Qin Min, et al.
Published: (2021-01-01) -
Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
by: Shaswath S. Chandrasekar, et al.
Published: (2021-02-01) -
SARS-CoV-2 Vaccines: Inactivation by Gamma Irradiation for T and B Cell Immunity
by: Arno Mullbacher, et al.
Published: (2020-11-01)